ANIB1 overexpression

News alerts, weekly reports and conference planners

Entrez ID:

ANIB1 overexpression	Breast Cancer	ANIB1 overexpression	Breast Cancer	tamoxifen Resistant: B - Late Trials tamoxifen Resistant : B	tamoxifen Resistant: B - Late Trials tamoxifen Resistant : B
ANIB1 overexpression	Pancreatic Ductal Adenocarcinoma	ANIB1 overexpression	Pancreatic Ductal Adenocarcinoma	GANT1 Sensitive: D – Preclinical GANT1 Sensitive : D	GANT1 Sensitive: D – Preclinical GANT1 Sensitive : D
ANIB1 overexpression	Pancreatic Ductal Adenocarcinoma	ANIB1 overexpression	Pancreatic Ductal Adenocarcinoma	GANT61 Sensitive: D – Preclinical GANT61 Sensitive : D	GANT61 Sensitive: D – Preclinical GANT61 Sensitive : D
ANIB1 overexpression	Pancreatic Ductal Adenocarcinoma	ANIB1 overexpression	Pancreatic Ductal Adenocarcinoma	Hedgehog cell-signalling pathway inhibitor Sensitive: D – Preclinical Hedgehog cell-signalling pathway inhibitor Sensitive : D	Hedgehog cell-signalling pathway inhibitor Sensitive: D – Preclinical Hedgehog cell-signalling pathway inhibitor Sensitive : D
ANIB1 overexpression	Pancreatic Ductal Adenocarcinoma	ANIB1 overexpression	Pancreatic Ductal Adenocarcinoma	cyclopamine Sensitive: D – Preclinical cyclopamine Sensitive : D	cyclopamine Sensitive: D – Preclinical cyclopamine Sensitive : D
ANIB1 overexpression	Pancreatic Ductal Adenocarcinoma	ANIB1 overexpression	Pancreatic Ductal Adenocarcinoma	sonidegib Sensitive: D – Preclinical sonidegib Sensitive : D	sonidegib Sensitive: D – Preclinical sonidegib Sensitive : D

Associations